Mauritius vs Portugal: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Mauritius
98.0%
in 2025
Portugal
98.0%
in 2025
Mauritius rank
10th
Portugal rank
10th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Mauritius
- Portugal
How they compare
Mauritius currently reports 98.0% against 98.0% in Portugal, a difference of 0.0%.
Across all 18 years both countries report, Portugal has been ahead every year.
Mauritius ranks 10th and Portugal ranks 10th of 192 countries.
Portugal has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mauritius | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 28.7% | 36.5% | 7.8% | Portugal |
| 2020s | 95.0% | 98.0% | 3.0% | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Mauritius or Portugal?
- Mauritius, at 98.0% against 98.0% in Portugal as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Mauritius and Portugal?
- 0.0%, with Mauritius ahead.
- How many years of comparable data are there for Mauritius and Portugal?
- 18 years are reported by both, from 2008 to 2025.
- How do Mauritius and Portugal rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Mauritius ranks 10th and Portugal ranks 10th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.